High-grade Serous Ovarian Carcinoma (HGSOC) Recruiting Phase 2 Trials for Defactinib (DB12282)

Also known as: B. High Grade Serous Ovarian Cancer / Ovarian High Grade Serous Carcinoma / High-grade Serous Ovarian Cancer / High-grade Serous Ovarian Carcinoma / High Grade Serous Ovarian Carcinoma / High Grade Serous Ovarian Cancer / High Grade Ovarian Serous / High Grade Serous Ovarian

IndicationStatusPhase
DBCOND0140551 (High-grade Serous Ovarian Carcinoma (HGSOC))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05512208A Phase 2 Study of Avutometinib (VS-6766) Plus DefactinibTreatment